Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ralph Corey

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 21, 2009
Staphylococcus aureus bloodstream infections: definitions and treatmentG Ralph Corey
International Journal of Antimicrobial Agents|September 9, 2008
Risk of intravascular cardiac device infections in patients with bacteraemia: impact on device removalG Ralph Corey, Tahaniyat Lalani
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2009
A balancing act: microbe versus muscleSara E Cosgrove, G Ralph Corey
Expert Opinion on Investigational Drugs|February 14, 2012
Tedizolid (TR-701): a new oxazolidinone with enhanced potencyZeina A Kanafani, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2013
Methicillin-resistant Staphylococcus aureus: an evolving pathogenMartin E Stryjewski, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the goodG Ralph Corey, Martin E Stryjewski
Future Microbiology|February 12, 2009
Ceftaroline: a cephalosporin with expanded Gram-positive activityZeina A Kanafani, G Ralph Corey
Current Opinion in Critical Care|June 30, 2009
New treatments for methicillin-resistant Staphylococcus aureusMartin E Stryjewski, G Ralph Corey
Therapeutics and Clinical Risk Management|June 6, 2015
New developments in the management of severe skin and deep skin structure infections - focus on tedizolidMichael J Durkin, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2008
Epidemiology of methicillin-resistant Staphylococcus aureusHelen W Boucher, G Ralph Corey
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 21, 2009
Staphylococcus aureus bloodstream infections: definitions and treatmentG Ralph Corey
International Journal of Antimicrobial Agents|September 9, 2008
Risk of intravascular cardiac device infections in patients with bacteraemia: impact on device removalG Ralph Corey, Tahaniyat Lalani
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2009
A balancing act: microbe versus muscleSara E Cosgrove, G Ralph Corey
Expert Opinion on Investigational Drugs|February 14, 2012
Tedizolid (TR-701): a new oxazolidinone with enhanced potencyZeina A Kanafani, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2013
Methicillin-resistant Staphylococcus aureus: an evolving pathogenMartin E Stryjewski, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the goodG Ralph Corey, Martin E Stryjewski
Future Microbiology|February 12, 2009
Ceftaroline: a cephalosporin with expanded Gram-positive activityZeina A Kanafani, G Ralph Corey
Current Opinion in Critical Care|June 30, 2009
New treatments for methicillin-resistant Staphylococcus aureusMartin E Stryjewski, G Ralph Corey
Therapeutics and Clinical Risk Management|June 6, 2015
New developments in the management of severe skin and deep skin structure infections - focus on tedizolidMichael J Durkin, G Ralph Corey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2008
Epidemiology of methicillin-resistant Staphylococcus aureusHelen W Boucher, G Ralph Corey
Pageof 16